Literature DB >> 19508427

Homocysteine-NMDA receptor-mediated activation of extracellular signal-regulated kinase leads to neuronal cell death.

Ranjana Poddar1, Surojit Paul.   

Abstract

Hyperhomocysteinemia is an independent risk factor for stroke and neurological abnormalities. However, the underlying cellular mechanisms by which elevated homocysteine can promote neuronal death is not clear. In the present study we have examined the role of NMDA receptor-mediated activation of the extracellular signal-regulated kinase-mitogen-activated protein (ERK-MAP) kinase pathway in homocysteine-dependent neurotoxicity. The study demonstrates that in neurons l-homocysteine-induced cell death was mediated through activation of NMDA receptors. The study also shows that homocysteine-dependent NMDA receptor stimulation and resultant Ca2+ influx leads to rapid and sustained phosphorylation of ERK-MAP kinase. Inhibition of ERK phosphorylation attenuates homocysteine-mediated neuronal cell death thereby demonstrating that activation of ERK-MAP kinase signaling pathway is an intermediate step that couples homocysteine-mediated NMDA receptor stimulation to neuronal death. The findings also show that cAMP response-element binding protein (CREB), a pro-survival transcription factor and a downstream target of ERK, is only transiently activated following homocysteine exposure. The sustained activation of ERK but a transient activation of CREB together suggest that exposure to homocysteine initiates a feedback loop that shuts off CREB signaling without affecting ERK phosphorylation and thereby facilitates homocysteine-mediated neurotoxicity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19508427      PMCID: PMC2748669          DOI: 10.1111/j.1471-4159.2009.06207.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  78 in total

1.  Homocysteine and brain atrophy on MRI of non-demented elderly.

Authors:  T den Heijer; S E Vermeer; R Clarke; M Oudkerk; P J Koudstaal; A Hofman; M M B Breteler
Journal:  Brain       Date:  2003-01       Impact factor: 13.501

2.  Immature and mature cortical neurons engage different apoptotic mechanisms involving caspase-3 and the mitogen-activated protein kinase pathway.

Authors:  Christian Lesuisse; Lee J Martin
Journal:  J Cereb Blood Flow Metab       Date:  2002-08       Impact factor: 6.200

3.  NMDA-mediated activation of the tyrosine phosphatase STEP regulates the duration of ERK signaling.

Authors:  Surojit Paul; Angus C Nairn; Ping Wang; Paul J Lombroso
Journal:  Nat Neurosci       Date:  2003-01       Impact factor: 24.884

4.  Mitogen-activated protein kinase inhibition in traumatic brain injury: in vitro and in vivo effects.

Authors:  Tatsuro Mori; Xiaoying Wang; Jae-Chang Jung; Toshihisa Sumii; Aneesh B Singhal; M Elizabeth Fini; C Edward Dixon; Alessandro Alessandrini; Eng H Lo
Journal:  J Cereb Blood Flow Metab       Date:  2002-04       Impact factor: 6.200

5.  Multiple aspects of homocysteine neurotoxicity: glutamate excitotoxicity, kinase hyperactivation and DNA damage.

Authors:  Pei I Ho; Daniela Ortiz; Eugene Rogers; Thomas B Shea
Journal:  J Neurosci Res       Date:  2002-12-01       Impact factor: 4.164

6.  Homocysteine-evoked 45Ca release in the rabbit hippocampus is mediated by both NMDA and group I metabotropic glutamate receptors: in vivo microdialysis study.

Authors:  Jerzy W Lazarewicz; Apolonia Ziembowicz; Ewa Matyja; Aleksandra Stafiej; Elzbieta Zieminska
Journal:  Neurochem Res       Date:  2003-02       Impact factor: 3.996

7.  L-homocysteine sulfinic acid and other acidic homocysteine derivatives are potent and selective metabotropic glutamate receptor agonists.

Authors:  Qi Shi; Jason E Savage; Sandra J Hufeisen; Laura Rauser; Ewa Grajkowska; Paul Ernsberger; Jarda T Wroblewski; Joseph H Nadeau; Bryan L Roth
Journal:  J Pharmacol Exp Ther       Date:  2003-04       Impact factor: 4.030

8.  Homocysteine-induced brain lipid peroxidation: effects of NMDA receptor blockade, antioxidant treatment, and nitric oxide synthase inhibition.

Authors:  Aurelio Jara-Prado; Alberto Ortega-Vazquez; Leticia Martinez-Ruano; Camilo Rios; Abel Santamaria
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

9.  CREB is required for acquisition of ischemic tolerance in gerbil hippocampal CA1 region.

Authors:  Tsuyoshi Hara; Jun-ichiro Hamada; Shigetoshi Yano; Motohiro Morioka; Yutaka Kai; Yukitaka Ushio
Journal:  J Neurochem       Date:  2003-08       Impact factor: 5.372

10.  Role of group I metabotropic glutamate receptors and NMDA receptors in homocysteine-evoked acute neurodegeneration of cultured cerebellar granule neurones.

Authors:  Elzbieta Ziemińska; Aleksandra Stafiej; Jerzy W Łazarewicz
Journal:  Neurochem Int       Date:  2003 Sep-Oct       Impact factor: 3.921

View more
  46 in total

1.  Hyperhomocysteinemia leads to exacerbation of ischemic brain damage: Role of GluN2A NMDA receptors.

Authors:  Ankur Jindal; Sathyanarayanan Rajagopal; Lucas Winter; Joshua W Miller; Donald W Jacobsen; Jonathan Brigman; Andrea M Allan; Surojit Paul; Ranjana Poddar
Journal:  Neurobiol Dis       Date:  2019-03-15       Impact factor: 5.996

2.  The neurotoxic effects of estrogen on ischemic stroke in older female rats is associated with age-dependent loss of insulin-like growth factor-1.

Authors:  Amutha Selvamani; Farida Sohrabji
Journal:  J Neurosci       Date:  2010-05-19       Impact factor: 6.167

3.  Effect of Hyperhomocysteinemia on Redox Balance and Redox Defence Enzymes in Ischemia-Reperfusion Injury and/or After Ischemic Preconditioning in Rats.

Authors:  Martin Petráš; Anna Drgová; Mária Kovalská; Zuzana Tatarková; Barbara Tóthová; Oľga Križanová; Ján Lehotský
Journal:  Cell Mol Neurobiol       Date:  2017-02-16       Impact factor: 5.046

4.  Role of GluN2A NMDA receptor in homocysteine-induced prostaglandin E2 release from neurons.

Authors:  Sathyanarayanan Rajagopal; Ashley Anne Fitzgerald; Satya Narayan Deep; Surojit Paul; Ranjana Poddar
Journal:  J Neurochem       Date:  2019-06-20       Impact factor: 5.372

5.  GluN2A-NMDA receptor-mediated sustained Ca2+ influx leads to homocysteine-induced neuronal cell death.

Authors:  Satya Narayan Deep; Sumonto Mitra; Sathyanarayanan Rajagopal; Surojit Paul; Ranjana Poddar
Journal:  J Biol Chem       Date:  2019-06-05       Impact factor: 5.157

6.  3-Hydroxy-3-Methylglutaric Acid Impairs Redox and Energy Homeostasis, Mitochondrial Dynamics, and Endoplasmic Reticulum-Mitochondria Crosstalk in Rat Brain.

Authors:  Mateus Struecker da Rosa; Nevton Teixeira da Rosa-Junior; Belisa Parmeggiani; Nícolas Manzke Glänzel; Leonardo de Moura Alvorcem; Rafael Teixeira Ribeiro; Mateus Grings; Moacir Wajner; Guilhian Leipnitz
Journal:  Neurotox Res       Date:  2019-11-13       Impact factor: 3.911

7.  P38 MAPK inhibition protects against glutamate neurotoxicity and modifies NMDA and AMPA receptor subunit expression.

Authors:  Martha Catalina Rivera-Cervantes; Rolando Castañeda-Arellano; Ruben Darío Castro-Torres; Graciela Gudiño-Cabrera; Alfredo I Feria y Velasco; Antoni Camins; Carlos Beas-Zárate
Journal:  J Mol Neurosci       Date:  2014-08-30       Impact factor: 3.444

8.  Homocysteine reduces NMDAR desensitization and differentially modulates peak amplitude of NMDAR currents, depending on GluN2 subunit composition.

Authors:  Andrew D Bolton; Marnie A Phillips; Martha Constantine-Paton
Journal:  J Neurophysiol       Date:  2013-07-17       Impact factor: 2.714

9.  Hydrogen Sulfide Epigenetically Attenuates Homocysteine-Induced Mitochondrial Toxicity Mediated Through NMDA Receptor in Mouse Brain Endothelial (bEnd3) Cells.

Authors:  Pradip K Kamat; Anuradha Kalani; Suresh C Tyagi; Neetu Tyagi
Journal:  J Cell Physiol       Date:  2015-02       Impact factor: 6.384

10.  Dyrk1A, a serine/threonine kinase, is involved in ERK and Akt activation in the brain of hyperhomocysteinemic mice.

Authors:  Sabiha Abekhoukh; Chris Planque; Clémentine Ripoll; Paulina Urbaniak; Jean-Louis Paul; Jean-Maurice Delabar; Nathalie Janel
Journal:  Mol Neurobiol       Date:  2012-08-26       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.